Identifying and validating ITGB2 and HNRNPAB as diagnostic biomarkers in chronic obstructive pulmonary disease using bioinformatics and Integrated Machine Learning Methods

BACKGROUND AND AIM: COPD is a common respiratory disease characterized by progressive airflow restriction that severely affects patients' quality of life and leads to significant mortality rates worldwide. This study aims to strengthen the early diagnosis of COPD and develop personalized treatment strategies. METHODS: The methodology involved a comprehensive approach, including differential gene expression analysis, weighted gene co-expression network analysis (WGCNA), functional enrichment analysis, and machine learning techniques. Data from the combined datasets GSE37768 and GSE38974 were utilized to identify differentially expressed genes (DEGs). The machine learning integrated model was employed to screen for diagnostic molecular biomarkers related to COPD. Additionally, pathway analysis, transcription factor gene regulatory network analysis, immune cell composition analysis using CIBERSORT, and mendelian randomization analysis were conducted to elucidate the molecular mechanisms and potential biomarkers for COPD. Finally, we validated the model using Polymerase Chain Reaction (PCR), immunohistochemistry (IHC) and Immunofluorescence (IF). RESULTS: This study employed bioinformatics and Integrated Machine Learning Methods to identify ITGB2 and HNRNPAB as potential related targets for COPD. Subsequent verification through PCR, IHC, and IF experiments confirmed that ITGB2 and HNRNPAB were key biomarkers for COPD. Pathway analysis revealed that ITGB2 and HNRNPAB were mainly involved in immune responses and metabolic pathways. CONCLUSION: This comprehensive study presents an in-depth investigation of the molecular mechanisms of COPD and identifies candidate exploratory biomarkers for further research toward early diagnosis and potential personalized treatment strategies. In future studies, the identified exploratory biomarkers should be validated in larger cohorts and their therapeutic significance explored.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-05-21
DOI
https://doi.org/10.1371/journal.pone.0349338
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identifying and validating ITGB2 and HNRNPAB as diagnostic biomarkers in chronic obstructive pulmonary disease using bioinformatics and Integrated Machine Learning Methods

Wenchang Xu, Yuchen He, Dexian Xian, Li, Hui, 1970- et al.
PLoS ONE
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Identifying and validating ITGB2 and HNRNPAB as diagnostic biomarkers in chronic obstructive pulmonary disease using bioinformatics and Integrated Machine Learning Methods

Wenchang Xu, Yuchen He, Dexian Xian, Li, Hui, 1970-, Feng Chen, Xiaodan Liu, Wei Zhang, Fan Wu, Fengjun Zhang
article en

Abstract

BACKGROUND AND AIM: COPD is a common respiratory disease characterized by progressive airflow restriction that severely affects patients' quality of life and leads to significant mortality rates worldwide. This study aims to strengthen the early diagnosis of COPD and develop personalized treatment strategies. METHODS: The methodology involved a comprehensive approach, including differential gene expression analysis, weighted gene co-expression network analysis (WGCNA), functional enrichment analysis, and machine learning techniques. Data from the combined datasets GSE37768 and GSE38974 were utilized to identify differentially expressed genes (DEGs). The machine learning integrated model was employed to screen for diagnostic molecular biomarkers related to COPD. Additionally, pathway analysis, transcription factor gene regulatory network analysis, immune cell composition analysis using CIBERSORT, and mendelian randomization analysis were conducted to elucidate the molecular mechanisms and potential biomarkers for COPD. Finally, we validated the model using Polymerase Chain Reaction (PCR), immunohistochemistry (IHC) and Immunofluorescence (IF). RESULTS: This study employed bioinformatics and Integrated Machine Learning Methods to identify ITGB2 and HNRNPAB as potential related targets for COPD. Subsequent verification through PCR, IHC, and IF experiments confirmed that ITGB2 and HNRNPAB were key biomarkers for COPD. Pathway analysis revealed that ITGB2 and HNRNPAB were mainly involved in immune responses and metabolic pathways. CONCLUSION: This comprehensive study presents an in-depth investigation of the molecular mechanisms of COPD and identifies candidate exploratory biomarkers for further research toward early diagnosis and potential personalized treatment strategies. In future studies, the identified exploratory biomarkers should be validated in larger cohorts and their therapeutic significance explored.

PLoS ONEVol. 21(5)
Shandong University of Traditional Chinese Medicine (CN), Yuhuangding Hospital (CN), Shanghai University of Traditional Chinese Medicine (CN), Shanghai Traditional Chinese Medicine Hospital (CN), Shuguang Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Openalex Percentile: Top 6%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.